publicações selecionadas
-
artigo académico
- Aspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants Pseudomonas aeruginosa isolates in in vitro cystic fibrosis airway mucus. Biofilms. 2025
- Lignin-based nanoparticles loading essential oils with potential for diabetic foot infection management. ACS Materials AU. 2025
- Mechanistic Insights into Succinic Acid as an Adjuvant for Ciprofloxacin in Treating Pseudomonas aeruginosa Growing Within Cystic Fibrosis Airway Mucus. African Journal of Biotechnology. 2024
- Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants. Frontiers in Cellular and Infection Microbiology. 2020
-
documento